SOPHiA GENETICS Schedules Q2 2024 Financial Results Announcement
Curated by THEOUTPOST
On Tue, 23 Jul, 4:05 PM UTC
2 Sources
2 Sources
[1]
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024
BOSTON and ROLLE, Switzerland, July 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal year 2024 before U.S. markets open on Tuesday, August 6, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion. About SOPHiA GENETICS SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDMâ„¢ Platform, a cloud-native platform that analyzes complex multimodal data - including genomics, radiomics, clinical, biological, and digital pathology data - to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
[2]
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024 By Investing.com
BOSTON and ROLLE, Switzerland, July 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal year 2024 before U.S. markets open on Tuesday, August 6, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion. About SOPHiA GENETICS SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDMâ„¢ Platform, a cloud-native platform that analyzes complex multimodal data " including genomics, radiomics, clinical, biological, and digital pathology data " to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
Share
Share
Copy Link
SOPHiA GENETICS, a cloud-native software company in the healthcare space, has announced it will release its financial results for the second quarter of 2024 on August 6, 2024. The company will also host a conference call to discuss the results on the same day.
SOPHiA GENETICS Sets Date for Q2 2024 Financial Results
SOPHiA GENETICS SA (Nasdaq: SOPH), a leading cloud-native software company in the healthcare sector, has announced the date for its second quarter 2024 financial results release. The company will unveil its financial performance on Tuesday, August 6, 2024, before the U.S. financial markets open 1.
Conference Call Details
Following the release of the financial results, SOPHiA GENETICS will host a conference call and webcast at 8:30 a.m. Eastern Time / 2:30 p.m. Central European Time on the same day. This call will provide an opportunity for investors and analysts to delve deeper into the company's performance and future outlook 2.
Accessing the Conference Call
Interested parties can access the live call through various means:
- Webcast: A live and archived webcast will be available on the company's website in the Investor Relations section 1.
- Telephone: Participants can join via telephone by dialing 1-877-270-2148 (US) or 1-412-902-6510 (International) 2.
To ensure a timely connection, it is recommended that participants join at least 15 minutes before the call begins 1.
About SOPHiA GENETICS
SOPHiA GENETICS is at the forefront of data-driven medicine, leveraging AI and machine learning to develop innovative technologies for healthcare professionals. The company's platform, SOPHiA DDM, is designed to analyze and interpret complex genomic data, assisting in clinical decision making across various medical disciplines including oncology, rare diseases, and cardiology 12.
Investor Relations and Further Information
For those unable to attend the live call, a replay will be available on the company's website shortly after the conference concludes. Additionally, SOPHiA GENETICS maintains an investor relations section on their website where stakeholders can find more information about the company's financial performance and strategic initiatives 12.
This upcoming financial results announcement is expected to provide valuable insights into SOPHiA GENETICS' performance in the rapidly evolving field of AI-driven healthcare solutions. As the company continues to expand its reach and refine its technologies, investors and industry observers alike will be keen to see how these developments translate into financial outcomes for the second quarter of 2024.
Reference
[1]
SOPHiA GENETICS Showcases Advancements in Cancer Care at ESMO 2024
SOPHiA GENETICS announces updates on its SOPHiA UNITY platform and poster presentations at the European Society for Medical Oncology (ESMO) 2024 Congress, highlighting progress in precision medicine for cancer treatment.
2 Sources
2 Sources
SOPHiA GENETICS Expands Partnership with Canadian Oncology Lab OncoHelix
SOPHiA GENETICS, a cloud-native software company in the healthcare space, has announced an expanded relationship with OncoHelix, a Canadian molecular diagnostics laboratory. This partnership aims to enhance cancer care through advanced genomic analysis.
2 Sources
2 Sources
SOPHiA GENETICS Unveils Groundbreaking AI-Driven Patient Stratification Research at ESMO 2024
SOPHiA GENETICS presents innovative multimodal research on AI-driven patient stratification at ESMO 2024, showcasing advancements in precision medicine for cancer treatment.
2 Sources
2 Sources
Veracyte Announces Release Date for Q2 2024 Financial Results
Veracyte, Inc., a leading genomic diagnostics company, has scheduled the release of its second quarter 2024 financial results for August 6, 2024, after the close of the U.S. stock market. The company will also host a conference call to discuss the results and provide a business update.
2 Sources
2 Sources
Sapiens International Corporation to Release Q2 2024 Financial Results on August 1, 2024
Sapiens International Corporation N.V. has announced that it will publish its financial results for the second quarter of 2024 on August 1, 2024. The company will also host a conference call and webcast on the same day to discuss the results.
2 Sources
2 Sources
Your one-stop AI hub
The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.
The Outpost
Keep in touch
© 2025 TheOutpost.AI All rights reserved